Searchable abstracts of presentations at key conferences in endocrinology

ea0099rc5.8 | Rapid Communications 5: Pituitary and Neuroendocrinology | Part I | ECE2024

Outcomes of transsphenoidal surgery for producing pituitary adenomas in spain

Paja Fano Miguel , Hanzu Felicia , Angeles Galvez Mª , Villar Rocio , Moure Dolores , Menendez Edelmiro , Gonzalez-Fernandez Laura , Egana Nerea , Camara Rosa , Penalver David , Simo Andreu , Asensio-Wandosell Diego , Tenorio Carmen , Novo Cristina , Calatayud Maria , Pico Antonio , Sottile Johana , Diaz-Soto Gonzalo , Penalver David , Araujo-Castro Marta , Soto Alfonso , De Pablos Pedro , Aulinas Anna , Munoz Fernando , Biagetti Betina

In our country, as in others, there is a lack of data on the success rate of transsphenoidal surgery for producing pituitary adenomas. We evaluated the results reported in TESSPAIN, a retrospective multicenter nationwide project that includes all the TSS performed in the participating centers in the period between 2018 and 2022, both included. Surgical treatment success is defined according to the published criteria for each disease: normal IGF-1 and GH after 75 g of oral gluc...

ea0081p140 | Pituitary and Neuroendocrinology | ECE2022

Efficacy of lanreotide 120 mg primary therapy on tumor shrinkage and ophthalmologic symptoms in acromegaly after one month

Benderradji Hamza , Elise Vernotte , Ares Gustave Soto , Jean Philippe Woillez , Romain Perbet , Melodie-Anne Karnoub , Benoit Soudan , Arnaud Jannin , Assaker Richard , Luc Buee , Prevot Vincent , Claude-Alain Maurage , Pascal Pigny , Marie-Christine Vantyghem , Emilie Merlen , Cortet Rudelli Christine

Introduction: Few studies to date have attempted to evaluate the early efficacy of first-generation somatostatin analogs in somatotroph macroadenomas.Objective: To investigate the short-term efficacy of primary therapy with lanreotide 120 mg on tumor shrinkage and ophthalmologic symptoms in newly diagnosed patients with acromegaly.Design and patients: This single-center retrospective study included 21 patients who were newly diagno...

ea0090rc2.3 | Rapid Communications 2: Thyroid | ECE2023

A simplified four-tier classification of thyroid core needle biopsies (CNB) is an efficient system. Evidence based on more than 1,000 surgical cases

Paja Fano Miguel , Zabala Rosa , Korta Igone , Delgado Sandra , Luis Del Cura Jose , Rodriguez-Soto Josune , Izquierdo Jon , Garai Jon , Oleaga Amelia , Teresa Gutierrez M. , Exposito Amaia , Zufiaurre Maite , Ugalde Aitziber

CNB is increasingly being used as a diagnostic test for thyroid nodules with an inadequate (Bethesda 1) or indeterminate (Bethesda 3 and 4) FNAC results, which can account for up to 30% of the samples in some studies. CNB, using larger specimens and histological sections rather than cytological samples, allows better definition. We propose a simplified four-tiered classification of CNB specimens instead of the Bethesda system and evaluate its efficiency compared to definitive ...

ea0090rc6.3 | Rapid Communications 6: Endocrine-related Cancer | ECE2023

Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain

Lamas Cristina , Remon Pablo , Soto-Moreno Alfonso , Fajardo-Montanana Carmen , Biagetti Betina , Guerrero Fernando , Castro Marta Araujo , Mora Mireia , Hanzu Felicia Alexandra , Iglesias Pedro , Garcia Centeno Rogelio , Camara-Gomez Rosa

Introduction: Current guidelines propose temozolomide (TMZ) as the first-line chemotherapy for aggressive pituitary neuroendocrine tumors (PitNETs), but no clinical trials have been conducted and clinical experience in this context is limited.Patients and methods: A retrospective study of patients with aggressive pitNETs treated with TMZ was conducted by the members of the Neuroendocrinology Working Area of the Spanish Society of Endocrinology and Nutrit...

ea0090rc8.5 | Rapid Communications 8: Calcium and Bone | ECE2023

Treatment of chronic hypoparathyroidism by Eneboparatide, a novel PTH receptor-1 agonist: Results from a phase 2a study

Istvan Takacs , Mezozi Emese , Soto Alfonso , Kamenicky Peter , Figueres Lucile , Angeles Galvez Moreno M. , Lemoine Sandrine , Borson-Chazot Francoise , Capel Ismael , Ovize Michel , OuldRouis Taha , Allas Soraya , Sumeray Mark , Mannstadt Michael

Background: Conventional therapy for chronic hypoparathyroidism (cHP) is often unable to maintain stable normal serum calcium (Ca) levels for a full 24 h, to control symptoms, to prevent the detrimental long-term effects on the kidney and to preserve normal bone architecture. Eneboparatide (AZP-3601) is a novel 36-amino-acid peptide specifically designed to activate the R0 conformation of the PTH receptor 1, that results in a prolonged calcemic response and a sustai...

ea0090rc8.6 | Rapid Communications 8: Calcium and Bone | ECE2023

Eneboparatide, a novel PTH 1 receptor agonist, induces rapid reduction and normalization of urinary calcium in chronic hypoparathyroid patients

Figueres Lucile , Takacs Istvan , Mezosi Emese , Soto Alfonso , Kamenicky Peter , Lemoine Sandrine , Borson-Chazot Francoise , Capel Ismael , Angeles Galvez Moreno M. , Ovize Michel , OuldRouis Taha , Allas Soraya , Sumeray Mark , Mannstadt Michael

Background: Conventional therapy with oral calcium (Ca) and active vitamin D (vitD) supplementation for chronic hypoparathyroidism (cHP) can induce or aggravate hypercalciuria and may lead to detrimental long-term renal complications. Eneboparatide (AZP-3601) is a novel 36-amino-acid peptide with a short half-life designed to activate the R0 conformation of the PTH 1 receptor which produces a prolonged calcemic response. This phase 2a study examined the effects of e...

ea0090p385 | Endocrine-related Cancer | ECE2023

Characterization of telomerase/shelterin system in endocrine intracranial tumors at clinical, transcriptomic, and functional levels

G-Garcia Miguel E. , Flores-Martinez Alvaro , De la Rosa-Herencia Ana S. , Cano Gonzales David , Cardenas Eugenio , Solivera Juan , Gahete Manuel D. , Soto-Moreno Alfonso , Angeles Galvez-Moreno Maria , Fuentes-Fayos Antonio C. , M Luque Raul

Intracranial tumors (IT) comprise a heterogenous group of neoplasias (e.g., pituitary/brain tumors and craniopharyngiomas), characterized by difficult diagnosis based on MRI, challenging prognostic predictors and lack of effective therapeutic strategies. In addition, these tumors are usually associated with neurological disorders and severe comorbidities (e.g., those associated with Cushing syndrome, Acromegaly, etc.), worsening the quality life of patients. In this context, s...

ea0090p542 | Late-Breaking | ECE2023

Characterization of RNA expression and clinical outcomes in patients with aggresive pituitary tumors treated with temozolomide

Venegas Moreno Eva , Remon Pablo , Dios-Fuentes Elena , Pinar Gutierrez Ana , Manuel Canelo Juan , Oliva Rosario , Alonso-Garcia Miriam , Cardenas Eugenio , Kaen Ariel , G-Garcia Miguel E. , Cano Gonzales David , Luque Raul M. , Soto-Moreno Alfonso

Methods: Descriptive retrospective study of the clinical outcomes and RNA expression in aggressive pituitary tumors treated with temozolomide. RNA expression was studied in tumor samples normalized to housekeeping genes including GH, POMC, PRL, αsub, FSH, LH, TSH, sst1, sst2, sst3, sst5, sst5b, sst5c, DR1, DR2T, DR2L, DR4, DR5, Ghrelin, In1-Ghrelin, GOAT, GHRR1b, AVPR1b, GHRH-R, GnRH-R, Ki-67, PTTG1, CRHR1.Results: Ten patients were treated. 30% (3)...

ea0090ep163 | Calcium and Bone | ECE2023

Evaluation of ultrasonography and 99mTc-sestamibi scintigraphy in the preoperative imaging study in Primary Hyperparathyroidism

Oleaga Amelia , Santamaria Alejandra , Goni Fernando , Moreno Cristina , Izuzquiza Ana , Espiga Javier , Arosa Vanessa , Monzon Andoni , Rodriguez-Soto Miren Josune , Izquierdo Jon , Iglesias Natalia , Garai Jon , Calles Laura , Hernando Inigo , Lizarraga Aitzol , Ugarte Estibaliz , Paja Miguel

Introduction: Minimally invasive surgery has become the standard surgical procedure in Primary Hyperparathyroidism (PHP). Targeted parathyroidectomy is associated with a shorter operative duration, a lower risk of complications and a greater patient satisfaction. This approach is dependent on precise localization of the abnormal gland. 99mTc-sestamibi scintigraphy and ultrasonography are acceptable imaging modalities to detect parathyroid adenoma prior to operation but discrep...

ea0090ep440 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Glycaemic control parameters in patients with diabetes mellitus secondary to exocrine pancreas diseases using flash glucose monitoring

Buigues Ana Ortola , Valverde Carla Valles , Hoyos Emilia Gomez , Sahagun Rebeca Jimenez , Lopez Gomez Juan Jose , Torres Beatriz Torres , Garcia Esther Delgado , Soto Gonzalo Diaz , Nieto de la Marca Maria de la O , de Luis Roman Daniel

Introduction: Diabetes mellitus secondary to exocrine pancreas diseases (pancreatogenic DM) has an unknown incidence and is considered underdiagnosed. Our objective was to evaluate the glycemic control parameters in patients with pancreatogenic DM who started Flash glucose monitoring (FGM).Methods: Prospective, observational study in a Spanish hospital. Patients with pancreatogenic DM who started FGM from January 2021 to August 2022 were recruited. Patie...